INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 439m ago
House PTR38m ago
SEC 13F38m ago
Robinhood Chain38m ago

Results

21,575 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$14.81M
99.0K sh
Apr 10, 2026Apr 14, 2026
Page 343 of 540
← PrevNext →
traded Apr 10, 2026
+4d
SEC Form 4

Evidence

24
KL
Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$65K
2,480 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

24
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$2.30M
48.5K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

22
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$480K
1,200 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

22
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$3.72M
24.7K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

21
Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$172K
1,749 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

20
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
14.3K sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

19
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$68K
8,310 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

18
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$238K
4,922 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

18
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$135K
2,735 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,725 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$11K
2,400 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,687 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$40K
8,500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$18K
3,732 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,706 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,830
1,014 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
990 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,399 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,442 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,764
1,000 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,003 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$387K
8,973 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$252K
5,927 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
HP
Hung PriscillaDirector
VEEVVEEVA SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$115K
750 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.07M
1,860 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

10
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$19K
2,693 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
10.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$780K
1,354 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$925K
1,603 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$838K
1,457 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

7
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale · 10b5-1 plan
SELL$546K
4,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
SB
Sevalia Piyush BSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$530K
1,247 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$1.15M
9,593 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

6
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$4,437
100 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$73K
614 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$359K
2,959 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$347K
601 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence